GOLDENWELL BIOTECH, INC. (GWLL) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2024 | $75 | -93.6% |
| 2023 | $1.2K | -94.8% |
| 2022 | $22.6K | +198.4% |
| 2021 | $7.6K | — |
| 2020 | $0 | — |
| 2019 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2024 | $75 | -93.6% |
| 2023 | $1.2K | -94.8% |
| 2022 | $22.6K | +198.4% |
| 2021 | $7.6K | — |
| 2020 | $0 | — |
| 2019 | $0 | — |